CRISPR Therapeutics AG
F:1CG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CRISPR Therapeutics AG
F:1CG
|
CH |
|
S
|
Stora Enso Oyj
STO:STE A
|
FI |
|
VP Bank AG
F:3VFN
|
LI |
|
Atex Resources Inc
OTC:ECRTF
|
CA |
|
I
|
Intermap Technologies Corp
OTC:ITMSF
|
US |
|
Faraday Future Intelligent Electric Inc
NASDAQ:FFAI
|
US |
|
C
|
Converge Technology Solutions Corp
F:0ZB
|
CA |
|
B
|
Brookside Energy Ltd
F:8F3
|
AU |
|
Deutsche EuroShop AG
OTC:DUSCF
|
DE |
|
C
|
Chow Tai Fook Jewellery Group Ltd
F:1CT
|
HK |
|
Encore Capital Group Inc
NASDAQ:ECPG
|
US |
|
Globe Trade Centre SA
F:G91
|
PL |
|
E
|
EVRAZ plc
XBER:EVZ
|
UK |
|
Ebusco Holding NV
F:8J30
|
NL |
|
Morepen Laboratories Ltd
BSE:500288
|
IN |
Bankruptcy Probability
CRISPR Therapeutics AG's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
CRISPR Therapeutics AG Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CH |
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
380.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
177.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
158.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
108.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
63.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
38.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
CRISPR Therapeutics AG's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, CRISPR Therapeutics AG has total debt of 585.5m USD. This includes both short-term (0 USD) and long-term (585.5m USD) debt.
You can find a full breakdown on its Balance Sheet.
